BIORESTORATIVE THERAPIES INC (BRTX) Stock Analyst Ratings
NASDAQ:BRTX - Nasdaq - US0906556065 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to BRTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.26. This target is 636.67% above the current price.
BRTX was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BRTX.
In the previous month the buy percentage consensus was at a similar level.
BRTX was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-08-14 | Roth MKM | Maintains | Buy -> Buy |
| 2024-06-12 | Roth MKM | Maintains | Buy -> Buy |
| 2023-08-14 | Roth MKM | Reiterate | Buy -> Buy |
| 2022-12-07 | Roth Capital | Initiate | Buy |
| 2022-09-28 | Maxim Group | Initiate | Buy |
| 2021-12-01 | Roth Capital | Initiate | Buy |